Other adverse events with an incidence 5% are as follows: abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distention, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and nasopharyngitis
Individual health conditions, such as pre-existing gastrointestinal issues or concurrent medications, can also play a significant role in how one reacts to semaglutide
However, its important to remember that weight loss is a gradual process and may not occur at the same rate for everyone
This compound medication not only assists in improving glycemic control but also enhances overall well-being
How can muscle loss be prevented while using GLP-1 drugs